Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	128K 148K 121K 109K 205K 14.14M 206K 1.43M 551K 7.19M 556K 544K 22.73M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.37M 12.54M 11.36M 21.32M 1.47B 21.43M 149M 57.25M 747M 57.71M 56.44M 2.36B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-29	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-29	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
28/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
06/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
25/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

09-09	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-26	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-29	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-29	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Safe Orthopaedics Stock Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news: Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	148K
STRYKER CORPORATION	+2.06%	-9.10%	-28.12%	-7.32%	106B
SMITH & NEPHEW PLC	+4.31%	-1.36%	-24.22%	-0.90%	11.47B
GLAUKOS CORPORATION	-1.84%	-5.76%	+102.09%	+119.72%	9.86B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.34%	-6.25%	-55.03%	-71.63%	3.94B
DOUBLE MEDICAL TECHNOLOGY INC.	-2.84%	-6.11%	-30.21%	+24.68%	2.33B
INSPIRE MEDICAL SYSTEMS, INC.	+7.16%	+15.73%	-8.81%	-66.55%	2.11B
INSIGHT LIFETECH CO., LTD.	+1.47%	-5.12%	-	-	1.84B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-2.10%	-4.52%	-23.51%	-31.17%	1.5B
Average	+0.59%	-3.01%	-9.69%	-4.74%	17.34B
Weighted average by Cap.	+1.32%	-7.89%	-18.87%	-0.11%

	2024	2025
Net sales	5.04M 5.85M 4.77M 4.33M 8.12M 559M 8.16M 56.69M 21.8M 284M 21.97M 21.49M 899M	5.36M 6.23M 5.08M 4.6M 8.64M 595M 8.68M 60.32M 23.2M 303M 23.38M 22.87M 956M
Net income	-1.93B -2.24B -1.83B -1.66B -3.11B -214B -3.12B -21.7B -8.34B -109B -8.41B -8.23B -344B	-4.67M -5.42M -4.43M -4.01M -7.53M -518M -7.56M -52.56M -20.21M -264M -20.37M -19.93M -833M
Net Debt	11.47M 13.31M 10.86M 9.84M 18.47M 1.27B 18.56M 129M 49.61M 647M 50M 48.9M 2.04B	13.11M 15.22M 12.42M 11.25M 21.11M 1.45B 21.22M 147M 56.7M 740M 57.15M 55.9M 2.34B